Integrating Wearable Devices Into Patient Care

What to do with wearables and the deluge of data they offer is a big question in the minds of IT leaders and a topic addressed well at HIMSS19 by Karl Poterack, MD, the medical director, applied clinical informatics, Mayo Clinic.

In the early years of wearables, most of the growth came from low-priced fitness trackers. But most recently, devices such as smartwatches, hearables, smart clothing and smart glasses are gaining in popularity across a broader audience.

According to a 2019 report, roughly a quarter of U.S. adults, some 56.7 million, were projected to use a wearable device at least once a month during 2019. That same report from eMarketer.com estimates that about half of adult wearable users regularly wear a smartwatch. An additional 3.8 million children and teens in the U.S. have a wearable device.

This all adds up to a lot of data for healthcare to deal with, coming from Apple Watches, Fitbits, Garmins and other devices. They data can potentially offer value to physicians caring for patients but there are not many examples of how to integrate the technology into today’s healthcare model, as Poterack noted.

"When tracking health data with wearables begins to integrate with healthcare organizations, it will be a tsunami of data," he said. "Fitbit alone has data on 3 trillion steps. That is just a portion of the data they collect. There has to be a place to put this data and we need to answer the question of who owns it, and how it is collected and what happens to it when it goes to hospitals, which all have a different sent of rules on data collection under HIPAA." 

To address these concerns and the volume of data available from these devices, Poterack said massive infrastructure would be needed. Yet, no one will make the investment until medical researchers establish guidelines or benchmarks for this data. For example, what it means when a cardiac patient logs 1,000 steps vs. 15,000 steps a day.

The largest barrier is what the healthcare system is going to do with the data, according to Poterack. "The challenge is really how to take this data and link it to outcomes."

Mary Tierney
Mary C. Tierney, MS, Vice President & Chief Content Officer, TriMed Media Group

Mary joined TriMed Media in 2003. She was the founding editor and editorial director of Health Imaging, Cardiovascular Business, Molecular Imaging Insight and CMIO, now known as Clinical Innovation + Technology. Prior to TriMed, Mary was the editorial director of HealthTech Publishing Company, where she had worked since 1991. While there, she oversaw four magazines and related online media, and piloted the launch of two magazines and websites. Mary holds a master’s in journalism from Syracuse University. She lives in East Greenwich, R.I., and when not working, she is usually running around after her family, taking photos or cooking.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.